Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets (Parenthetical)

v3.24.2.u1
Condensed Consolidated Balance Sheets (Parenthetical) - USD ($)
Jun. 30, 2024
Dec. 31, 2023
Deferred tax assets attributable to VIE $ 907,019 $ 1,031,648
Payroll liabilities attributable to VIE 4,272,155 3,485,744
Liabilities to be disposed of attributable to VIE 12,140,570 13,831,863
Other liabilities attributable to VIE $ 1,235,241 $ 1,235,241
Series A preferred stock, par value (in dollars per share) $ 0.001 $ 0.001
Series A preferred stock, shares authorized (in shares) 50,000 50,000
Series A preferred stock, shares issued (in shares) 0 0
Series A preferred stock, shares outstanding (in shares) 0 0
Common stock, par value (in dollars per share) $ 0.001 $ 0.001
Common stock, shares authorized (in shares) 20,000,000 20,000,000
Common stock, shares issued (in shares) 14,996,787 14,783,757
Common stock, shares outstanding (in shares) 14,963,772 14,751,633
Treasury stock, shares (in shares) 33,015 32,124
Variable Interest Entity, Primary Beneficiary    
Deferred tax assets attributable to VIE $ 1,088,802 $ 1,088,802
Payroll liabilities attributable to VIE 746,266 728,130
Deferred revenue from company clinics attributable to VIE 2,249,927 1,558,178
Liabilities to be disposed of attributable to VIE 2,819,436 3,622,481
Other liabilities attributable to VIE $ 1,235,241 $ 1,235,241